Salt-extracted microsomal membranes (K-RM) contain an activity that is capable of releasing the signal recognition particle (SRP)-mediated elongation arrest of the synthesis of secretory polypeptides (Walter, P., and G. Blobel, 1981, J. Cell Biol., 91:557-561). This arrestreleasing activity was shown to be a function of an integral microsomal membrane protein, termed the SRP receptor (Gilmore, R., P. Walter, and G. Blobel, 1982, J. Cell BioL, 95:470-477). We attempted to solubilize the arrest-releasing activity of the SRP receptor by mild protease digestion of K-RM using either trypsin or elastase. We found, however, that neither a trypsin, nor an elastase "solubilized" supernatant fraction exhibited the arrest-releasing activity. Only when either the trypsin-or elastase-derived supernatant fraction was combined with the trypsinized membrane fraction, which by itself was also inactive, was the arrest-releasing activity restored. Release of the elongation arrest was followed by the translocation of the secretory protein across the microsomal membrane and the removal of the signal peptide. Thus, although we have been unable to proteolytically sever the arrest-releasing activity from K-RM and thereby to uncouple the release of the elongation arrest from the process of chain translocation, we have been able to proteolytically dissect and reconstitute the arrest-releasing activity. Furthermore, we found that the arrest-releasing activity of the SRP receptor can be inactivated by alkylation of K-RM with N-ethylmaleimide.
in the wheat germ cell-free system, in the presence of SRP, did not yield synthesis of completed preprolactin molecules, but instead yielded synthesis of a discrete NH2 terminal segment of preprolactin comprising 60-70 amino acid residues (3) . When salt-extracted microsomal membranes (K-RM) were added to an SRP arrested cell-free translation system, the elongation arrest was released, followed by the translocation of nascent preprolactin across the microsomal membrane and the removal of the signal peptide by signal peptidase, thereby yielding segregated prolactin molecules (3) .
Our present work (here and in the following paper [9] ) was directed towards identifying, purifying, and characterizing the arrest-releasing activity contained in the K-RM fraction. Using immobilized SRP as an affinity adsorbent we isolated an integral membrane protein that exhibited the arrest-releasing activity. Because of the direct interaction of this protein with SRP we refer to it as the SRP receptor.
The existence of an SRP receptor had been postulated (3) based upon the following lines of evidence: (a) K-RM release the SRP-mediated elongation arrest of secretory protein synthesis, but phospholipid vesicles prepared from K-RM do not (3), (b) a salt-dependent interaction between SRP and RM is observed that is not disrupted by extraction of the ribosomes from the membrane with EDTA (10) , and (c) a membranebound component of the translocation system was previously detected using pretense digestions of K-RM (11, 12) . The SRP receptor was envisioned to fimction during the binding of the SRP-arrested ribosome to the membrane, thereby releasing the elongation arrest and initiating the translocation of the nascent chain (3) .
In this paper we describe a quantitative assay for the SRP receptor based upon its arrest-releasing activity. Using this assay we show (a) that the SRP receptor can be proteolytically dissected into a soluble cytoplasmic domain and a membranebound domain, (b) that neither the cytoplasmic domain nor the membrane-bound domain can release the translation arrest when assayed separately, but when the two fractions are combined the arrest-releasing activity is restored, (c) that the arrestreleasing activity is inhibited by treatment of K-RM with Nethylmaleimide (NEM), and (d) that the translocation of nascent secretory proteins occurs whenever the SRP-induced elongation arrest is released by the SRP receptor.
MATERIALS AND METHODS
Materials laSS]Met (1,000 Ci/mmol) was obtained from New England Nuclear, Boston, MA; trypsin from Boehringer Mannheim, Federal Republic of Germany, and elastase from Merck and Co., Inc., Federal Republic of Germany. Trasylol (10,000 kallikrein inhibitor U/ml) was from FBA Pharmaceuticals, New York, NY. Other pretense inhibitors were from Sigma Chemical Co., St. Louis, Me. The nonionic detergent Nikkol (oetaethyleneglycol-mono-N-dodecyl ether) was from Nikko Chemicals Co., Ltd., Tokyo, Japan.
Preparation of Microsomal Membranes, Signal Recognition Particle, and Salt-Extracted Microsomal Membranes
Rough microsomal membranes (RM), signal recognition particle (SRP), and salt-extracted rough microsomal membranes (K-RM) were prepared as described previously (1) except that adsorbed ribosomes were removed from RM by extraction with 25 mM EDTA (I 1) before the extraction of SRP. The gel filtration step using a Sepharose CL-2B colunm was omitted. The triethanolamine buffer used for all preparative procedures was prepared as a 1 M stock solution adjusted to pH 7.5 at room temperature with acetic acid and, as such, is referred to as TEA.
Protease Digestions of K-RM
K-RM were subjected to limited pretense digestions after suspending the membranes in l mI of 50 mM TEA, 1 mM dithiothreitol (DTT) at a membrane concentration of 2 eq/#l. Aliquots of a stock solution of trypsin were added to obtain the desired pretense concentrations (0-50 #g/ml of trypsin). After 60 min of incubation at 0°C, the samples were adjusted to 0.5 mM diisopropylfluorophosphate and incubated for an additional 15 rain at 0°C. Trasylol (100 #1) was added, and the concentration of KOAc was adjusted to 500 mM by the addition of the appropriate volume of 4 M KOAc. A trypsin-solubilized supernatant fraction was separated from the trypsinized membranes by centrifugation for 30 min at 100,000 g,v. The membranes were washed once by resuspension in 5 ml of 50 mM TEA, 0.25 M sucrose, 1 mM DTT, followed by centrifugation for 30 min at 100,000 g,v. The membrane pellet (Tx-K-RM, where x denotes the concentration of trypsin used in gtg/ml) was resuspended in 50 mM TEA, 0.25 M sucrose, 1 mM DTT, frozen in liquid N2, and stored at -80°C. The trypsinderived supernatant fraction was concentrated by ultrafiltration using an Amicon PM-30 membrane to a final volume of 200 #1. This supernatant fraction was applied to a 1.0 ml Sephadex G-25 column equilibrated in 50 mM TEA, 150 mM KOAc, 1 mM DTT. The excluded volume (300/~1) containing the proteasederived supernatant fraction (T:Sup) was collected, frozen in liquid N2 and stored at -80°C.
The elastase-derived supernatant fraction (El-Sup) was prepared in an identical manner except that the 10 mg/ml elastas¢ stock solution was pretreated with an equal volume of trasylol before use to inhibit nonelastolytic activity (12) . Trasylol was not added after the pretense digestion.
464 THE JOURNAL OF CELL B,OLOGV. VOLUME 95, 1982 NEM Alkylation of K-RM Dithiothreitol was removed from K-RM before treatment with NEM by ccntrift~gation and resuspension of the membranes in 50 mM TEA, 0.25 M sucrose. The samples were incubated with NEM at the specified concentration for 30 min at 25°C. The NEM was quenched with a 10-fold molar excess of DTTwith respect to sulfhydryl groups before use in the in vitro translations.
Assay for the Arrest-releasing Activity
A premixed aliquot of bovine pituitary RNA (0.08 A~o U/25 ~1 translation) and rabbit reticulocyte RNA (0.01 A~,o U/25/zl translation) was translated in a staphylococcal nuclease-treated (13) wheat germ system at 25°C for 1 h. The 25-/~1 translations contained 7.5/tl of wheat germ $23, 25 ~Ci of [35S]Met, and were supplemented with human placental RNase inhibitor (14) and a mixture of protease inhibitors described previously (1) . All translations were adjusted to a final ion concentration of 140 mM KOAc, 2.85 mM Mg (OAc)~. The translations contained 0.002% Nikkol to stabilize the SRP activity (6) . The 25-#1 translations were supplemented with 10 U of SRP to arrest the elongation of ~90% of the nascent preprolactin chains (1) . Control translations, which were not supplemented with SRP, were conducted for all experiments although in most cases the autoradiograph of the translation products of a control translation is not shown. The translations were further supplemented with K-RM or fractions derived from K-RM as described in the text and the figure legends.
PAGE in SDS
The procedures for the preparation of samples for PAGE (1, 15) , the subsequent autoradiography of dried slab gels (15) , and the quantitation of radioactivity in specific polypeptides have been described (1, 11) .
Definitions and Calculations
1 equivalent (eq) is the amount of a fraction (supernatant fluid or membrane) that is derived from l t~l of a RM suspension at a concentration of 50 A~ U/ml. 1 eq is derived from ~ 1 nag of tissue.
One unit of translocation activity (U) (a) for a membrane is the amount of membranes that gives the same amount of processing (i.e., translocation) as 1 cq ofRM, (b) for SRP is the amount that has to be added back to 1 eq of K-RM to restore activity to that of I eq of RM.
Bovine preprolactin contains eight methionyl residues (15, 16) , whereas prolactin contains seven (16) . The incorporation of [a~S]Met into prolactin was corrected for the loss of one methionyl residue contained within the signal peptide (15) using the ratio of 8/7. The incorporation of [~S]Met into both preprolactin (pPL) and prolactin (PL) was normalized with respect to the incorporation of laSS]Met into globin (GLO), which served as an internal standard in the arrestreleasing activity assay. For example, the globin-normalized incorporation of [25S]Met into prolactin (PLo) was calculated for an assay translation containing SRP and K-RM using the following formula:
where PL and GLO are the uncorrected cpm incorporated into prolactin and globin, respectively, in the assay translation, and GLO-is the uncorrected cpm incorporated into globin in the control translation that contained neither SRP nor K-RM. The percent SRP inhibition of preprolactin plus prolactin synthesis was calculated as below for the assay translation containing SRP and K-RM:
where pPLo and PLo are the globin-normalized incorporation of laSS]Met into preprolactin and prolactin in the assay translation, and pPL-and PL are the incorporation of laSS]Met into preprolactin and prolactin in the control translation. No incorporation of [~S]Met into prolactin (PL-) occurs in the control translation, so this term can be deleted from the denominator.
RESULTS

Assay for the Arrest-releasing Activity of the SRP Receptor
As a prerequisite for the characterization of the SRP receptor it was essential to develop a quantitative assay based on its arrest-releasing activity (3). The paradigm for this assay was to add a sufficient quantity of SRP to a cell-free translation system to induce an elongation arrest for >90% of the nascent preprolactin molecules. The arrest-releasing activity was then measured upon the addition of K-RM or K-RM-derived fractions. To distinguish between SRP-induced arrest and any nonspecific inhibition of the translation system by added fractions, we monitored the translation of globin mRNA, which is not affected by SRP (1) . Thus, globin mRNA, when cotranslated with preprolactin mRNA (under conditions in which neither RNA competes for translation) serves as an internal standard: the amount of newly synthesized globin can be used to normalize for nonspecific translation inhibitory effects caused by K-RM or fractions derived from K-RM.
The data from the arrest-releasing activity assays including necessary controls are generally displayed in several panels. The upper panel usually shows an autoradiograph of an SDS gel with the preprolactin (pPL), prolactin (PL), and globin (GLO) bands indicated. The lower panels usually show quantification of the autoradiographic data as (a) the incorporation of [asS]Met into preprolactin (pPL) and/or prolactin (PL) that is normalized with respect to the incorporation of [a~S]Met into globin and (b) the determination of the % inhibition of synthesis by SRP. A decrease in the percent inhibition corresponds to an increase in the arrest-releasing activity and as such represents the assay for the SRP receptor.
The data in Fig. 1 show that SRP can be added in a quantity such as to cause a >90% translation arrest of preprolactin synthesis (panel A, compare lane h (minus SRP) with lane a (plus SRP); for quantification see the data point corresponding to 0 eq of K-RM in panel C). Increasing the amounts of K-RM in the translation led to a release of the elongation arrest (note the increasing amounts of prolactin synthesized in lanes b--g of panel A; for quantification see the corresponding points in panels B and C). The release by K-RM of the SRP-induced translation arrest yields only prolactin, and not preprolactin (see panel B). This indicates that the translocation of secretory proteins is directly coupled to the release of the elongation arrest by the SRP receptor. A complete release (i.e., 0% inhibition) of the SRP-mediated translation arrest was not observed, as a significant generalized inhibition of translation occurred (for example, see GLO in lane g) when saturating quantities of K-RM were added to the assays. This inhibition prevented the accurate quantification of secretory protein synthesis at higher concentrations of K-RM.
Tryptic Dissection of the Arrestreleasing Activity
Trypsin digestion of K-RM has previously been used to demonstrate that K-RM contain integral membrane protein(s) required for translocation (11). Limited trypsin digestions were used to dissect this activity into a fraction containing trypsin "solubilized" fragment(s) that could be separated by centrifugation from a fraction containing the trypsinized membranes. The trypsin-digested membrane fraction was not translocation competent, but translocation could be restored by the addition of the solubilized fragment fraction to this membrane fraction (1 I). These experiments were confirmed (12) and extended: a 60,000-dalton protein fragment was purified from elastase digests of K-RM (17) and subsequently shown by immunoprecipitation to be derived from a 72,000-dalton integral membrane protein (18) .
We attempted to dissect the arrest-releasing activity of K-RM using an analogous limited protease digestion based upon the premise that the activity was associated with a protein domain located on the cytoplasmic side of the microsomal membrane and that the activity might be converted into a soluble form by mild proteolysis.
We therefore treated K-RM with various concentrations of trypsin. The incubation mixtures were separated by centrifugation into a soluble fraction (termed Tx-Sup, where x denotes the concentration of trypsin) and into a trypsinized membrane fraction (termed Tx-K-RM, with x again denoting the trypsin concentration used), and both fractions were assayed, either alone or in combination, in the SRP receptor assay.
The data in Fig. 2 (displayed in a manner similar to that of Fig. 1 ) demonstrated that the arrest-releasing activity present in K-RM was inactivated in T~-K-RM depending on the concentration of trypsin used in their preparation. To substantiate this conclusion we carried out a titration experiment in which we varied the concentrations of Tx-K-RM (resulting from incubation of K-RM with 0.0, 0.3, 1.0, 5.0, or 50 #g/ml of trypsin) in the SRP receptor assay. The data in Fig. 3 show that at low concentrations of trypsin (up to 0.3 #g/ml) there is little inactivation, whereas at high concentrations of trypsin (50 ptg/ml) there is an almost complete inactivation of arrest-releasing activity.
The Tx-Sup fraction derived by digestion of K-RM with trypsin concentrations of between 0.1 and 5.0 tzg/ml were then assayed (33 eq/assay) for arrest-releasing activity. However, it is apparent from the data shown in Fig. 4 (panel C, minus Ts-K-RM, the corresponding panel A and B data are not shown) that none of the T,-Sup fractions exhibited an arrest-releasing activity.
However, we observed reconstitution of the arrest-releasing activity (Fig. 4 , panel C, plus Ts-K-RM) when the Tx-Sup fractions were assayed in the presence of 1 cq of a trypsinized membrane fraction (Ts-K-RM), the latter being essentially inactive when assayed separately. It can be seen ( Fig. 4 ) that optimal reconstitution of the arrest-releasing activity occurred with a TL-SUp. The To.l-SUp was less effective, presumably because relatively less of the cytoplasmically exposed SRP receptor domain had been sohibilized. The Ts-Sup was also less active, presumably because some of the cytoplasmically exposed domain of the SRP receptor, although solubilized, had been inactivated at the higher trypsin concentration. These results were entirely analogous to those previously reported (11, 12) for the reconstitution of the translocation activity from protcolytically dissected K-RM.
The important point to be noted from the data shown in panel C of Fig. 4 is that when Ts-K-RM are omitted, none of the T,-Sup's exhibited the arrest-releasing activity by themselves. That is, the trypsin-solubilized cytoplasmic domain of the SRP receptor expresses the arrest-releasing activity only when reconstituted with component(s) that are present in the trypsinized membrane.
If effective rcconstitution of the release activity requires an interaction between the trypsin-solubilized cytoplasmic domain of the SRP receptor and the membrane-bound domain of the SRP receptor or some other membrane component, then extensive digestion of the K-RM with protease might also render this membrane-bound component incompetent for reconstitution. To test this hypothesis we assayed the To.a-Sup (40 eq) in conjunction with a series of T~-K-RM (1 eq) that had been Fig. 1. (C) The percent SRP inhibition of preprolactin plus prolactin synthesis (11) was determined as described in Fig. 1 The percent SRP inhibition of preprolactin plus prolactin synthesis was determined as described in Materials and Methods for the assays that were supplemented with both Ts-K-RM and a Tx-Sup fraction (II, corresponding to lanes a -e in panel A) and for the assays that were supplemented with 33 eq of the various Tx-Sup fractions (0, the corresponding translation products are not shown).
prepared from K-RM by digestion with trypsin concentrations of between 1.0 and 50.0 btg/ml. When the Tx-K-RM's were assayed without the added T0.3-Sup fraction no arrest-releasing activity was observed for membranes that were digested with >1 #g/ml of trypsin (see Fig. 5 , panel A, lanes a -e and panel B, open circles). When assayed in the presence of the T0.3-Sup (see Fig. 5 , panel A, lanes g-l, and panel B, closed circles) the various Tx-K-RM showed a comparably retarded loss of the arrest-releasing activity, but eventually, at the highest trypsin concentration (50.0 ~tg/ml), the reconstitutable arrest-releasing activity was virtually inactivated. We conclude that, at high trypsin concentrations, the membrane-bound domain of the SRP receptor or some other component required for reconstitution can be rendered incompetent for interaction with the cytoplasmic domain of the SRP receptor.
D i s s e c t i o n o f SRP R e c e p t o r b y Elastase
Our results so far show a striking analogy between the reconstitution of the translocation activity (11, 12) and the arrest-releasing activity using trypsin-derived fractions of K-RM, suggesting that a single component in the trypsin-derived supernatant fraction might be responsible for restoring these two activities. The active component responsible for restoring the translocation activity has been purified from elastase-solubilized supernatant fractions (17) , and was shown to be derived by proteolysis from an integral membrane protein (18) .
We determined whether elastase could also be used for the dissection of the arrest-releasing activity by digesting K-RM with 1 /~g/ml of elastase and, as in the case of the trypsin digestions, we prepared a supernatant fraction that we refer to as an EE-SUp. Increasing quantities of the El-SUp (derived from 0-33 eq of K-RM) were assayed either alone (Fig. 6, panel A , lanes a-~ panel B, minus Ts-K-RM) or together with 1 eq of trypsinized membranes (Fig. 6, panel A, lanes g-j, panel B, plus Ts-K-RM). The results show that, as observed in Fig. 4 for the Tx-Sup's, the Ez-Sup did not release the SRP-mediated translation arrest unless it was assayed in the presence of the proteolyzed membrane fraction, which in this case was again Ts-K-RM (we have not tested any E-K-RM). The following paper in this series demonstrates that the previously purified elastase fragment (17) is the cytoplasmic domain of the SRP receptor (9) .
Inhibition of Arrest-releasing Activity by NEM
To test the sulfhydryl group requirement of the arrest-releasing activity, K-RM were incubated with N-ethylmaleimide (NEM) (ranging in concentration from 0 to 5 mM); the NEM was subsequently quenched with an excess of DTT (see Ma-terials and Methods) and the NEM-treated K-RM were assayed for their arrest-releasing activity. We found (data not shown) that as little as 1.0 mM NEM was sufficient to inactivate both the arrest-releasing activity and the translocation activity.
To substantiate this conclusion, we carried out a titration of NEM-treated K-RM. From the quantitative data shown in Fig.  7 it is evident that, over the concentration range tested, NEMtreated K-RM have lost their arrest-releasing activity. In control experiments, K-RM that were incubated with an excess of DTT before NEM treatment or that were incubated with DTT alone did not exhibit any change in their arrest-releasing activity (data not shown). Several unexplained discrepancies concerning the NEM sensitivity of K-RM exist between the results presented here, and those presented previously (19) . However, these differences could be due to an incomplete extraction of SRP from RM and the less quantitative approach used for the data analysis.
D I S C U S S I O N
A sensitive and quantitative assay was developed to measure the arrest-releasing activity of the SRP receptor in microsomal membranes. The paradigm of this assay was to add enough SRP to the cell-free wheat germ translation system so that >90% of all nascent preprolactin chains were arrested and then to measure the release of the arrest by the membrane-associated SRP receptor present in the added K-RM.
From previous studies (11, 12) it was known that the translocation activity of salt-extracted microsomal membranes could be dissected into domains using mild proteolysis. Cytoplasmically exposed domains could be separated by high speed centrifugation from membrane-bound domains. Translocation activity could be reconstituted when these fractions were recombined. Furthermore, it was demonstrated (11, 12) that proteolyric dissection and reconstitution required strictly controlled conditions: mild proteolysis yielded very little solubilization of the cytoplasmic domain(s), whereas more extensive proteolysis rendered both domains incompetent for reconstitution.
Analogous results were obtained here for the arrest-releasing activity of K-RM after dissection with either trypsin or elastase. A cytoplasmically exposed domain of the SRP receptor could be proteolytically severed and separated by high speed centrif- with the following quantities of a El-Sup fraction: ( a and g) 0.0 eq, ( b a n d h) 6.5 eq, (c) 13eq, ( d a n d i) 20.0 eq, (e) 26.5 eq, ( f a n d j) 33.0 eq. Translation products were resolved by SDS PAGE and visualized by autoradiography. (B) The percent SRP inhibition of preprolactin plus prolactin synthesis was calculated for the assays supplemented with the El-Sup fraction alone (41,, lanes a-f), or the assays supplemented with both the Ts-K-RM and the EI-Sup frac- lanes g-i) . The quantitation of the translation products and the calculations were performed as described in Materials and Methods.
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]-HE JOURNAL OF CELL BIOLOGY-VOLUME 95, 1982 ugation from a membrane-bound domain. A specific interaction between these two fractions was required to restore SRP receptor activity, as neither the solubilized nor the membranebound fraction alone showed the arrest-releasing activity. Moreover, reconstitution of the activity occurred only within a fairly narrow window of proteolytic conditions: too mild a proteolysis dissected only a few SRP receptors, whereas too severe a proteolysis rendered both fractions incompetent for reconstitution. Thus, the reconstitution of the arrest-releasing activity was not complete even when optimal conditions for the preparation of the soluble supernatant fraction were used. The failure of extensively digested membranes (i.e., T~o-K-RM) to function effectively in the reconstitution assay may be due to either the digestion of the membrane-bound domain of the SRP receptor or some other protein component that is required for the reconstitution process. With regard to the latter it should be noted that binding of monomeric ribosomes to membranes is inhibited by mild trypsinization of the membranes (20) , and that certain prominent microsomal membrane proteins such as ribophorin I (21, 22) are digested by mild proteolysis. Modification of K-RM with NEM inhibited both the translocation activity as observed previously (19) , and the arrestreleasing activity. Taken together then, our results here strongly suggest that the proteolytically dissected and reconstituted, NEM-sensitive translocation activity (1 l, 12, 17) is, in fact, at least in part, represented by the arrest-releasing activity and therefore the SRP receptor (3, 9) . The active component of the proteolytically solubilized translocation activity has been purified and shown to be an NEM-sensitive 60,000-dalton polypeptide 07). Antibodies, raised against this fragment, immunoprecipitated a 72,000-dalton integral membrane protein, strongly suggesting that the 60,000-dalton protein fragment was derived from a 72,000-dalton integral m e m b r a n e protein (18) .
In the companion paper (9) we describe our purification of the active SRP receptor by SRP-Sepharose affinity chromatography. We show that the SRP receptor is a 72,000-dalton protein that is chemically and immunologically related to the 60,000-dalton protein fragment and consequently appears to be identical to the immunoprecipitated 72,000-dalton parent molecule.
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